title: Retinoid agonist isotretinoin ameliorates obstructive renal injury.
abstract: OBJECTIVE
  Interstitial fibrosis is a major cause of end stage renal failure. Retinoids, which are involved in tissue repair and fibrosis, inhibit inflammatory and proliferative pathways. Therefore, we studied the dose dependent effects of the retinoid receptor agonist isotretinoin 13-cis retinoic acid in the unilateral ureteral obstruction model (UUO).
  
  
  METHODS
  Sham operated control rats were compared with UUO rats treated with vehicle (UUO-Veh), or low (5 mg/kg body weight (UUO-LD) or high (25 mg/kg) (UUO-HD) dose isotretinoin. Kidneys were evaluated using reverse transcriptase-polymerase chain reaction and immunohistology 7 days after UUO. Renal injury and fibrosis were quantified by immunostaining and expression measurements of the genes involved in renal fibrosis.
  
  
  RESULTS
  In UUO-Veh kidneys the interstitial area was expanded 5-fold but only 3-fold in UUO-HD and 3.5-fold in UUO-LD rats. Interstitial cell counts were 3-fold higher in UUO-Veh rats but significantly less in UUO-HD or UUO-LD animals. Tubular and interstitial cell proliferation was significantly higher in UUO-Veh rats compared with sham operated control plus vehicle animals but less so in UUO-LD and UUO-HD rats. In UUO-Veh rats interstitial infiltration by monocytes/macrophages was higher compared with unobstructed controls. It was significantly less after isotretinoin treatment. In UUO-Veh rats mRNA for procollagen I, and transforming growth factor-beta1 and II receptor was significantly increased. It was significantly less after treatment with isotretinoin. Fibronectin and collagen I immunostaining was also decreased by isotretinoin.
  
  
  CONCLUSIONS
  Since isotretinoin limits proliferation, inflammation and fibrosis after UUO, retinoids should be further investigated as potentially promising therapeutic agents for renal disease.
mesh_terms: D000818:Animals; D006869:Hydronephrosis / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D015474:Isotretinoin / Q000627:therapeutic use*; D008297:Male; D051381:Rats; D017208:Rats, Wistar; D012176:Retinoids / Q000819:agonists*; D014517:Ureteral Obstruction / Q000150:complications / Q000188:drug therapy* / Q000473:pathology
chemical_list: D012176:Retinoids; D015474:Isotretinoin